Jan 5 (Reuters) - Pharvaris NV PHVS.O :
* PHARVARIS PROVIDES BUSINESS UPDATE AND OUTLINES 2024
STRATEGIC
PRIORITIES
* PHARVARIS NV - JOCHEN KNOLLE, PH.D., TO TRANSITION TO
STRATEGIC
ADVISOR TO CEO AND EXECUTIVE COMMITTEE
* PHARVARIS NV - RAPIDE-3, A GLOBAL PHASE 3 CLINICAL STUDY
OF
DEUCRICTIBANT FOR ON-DEMAND TREATMENT OF HAE, TO INITIATE WITHIN
1H24
* PHARVARIS NV: CLOSING OF $300 MILLION UNDERWRITTEN
OFFERING
EXTENDS CASH RUNWAY
* PHARVARIS NV - PHARVARIS REMAINS DILIGENT IN ITS
OPERATIONAL
MANAGEMENT AND NOW HAS A CASH RUNWAY FOR AT LEAST TWO YEARS.
Source text for Eikon: ID:nGNX27nrSV
Further company coverage: PHVS.O
((Reuters.Briefs@thomsonreuters.com;))